Raymond James Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.6M Buy
866,170
+102,969
+13% +$9.03M 0.02% 709
2026
Q1
$69M Buy
763,201
+47,972
+7% +$4.4M 0.02% 682
2025
Q4
$64.3M Buy
715,229
+14,758
+2% +$1.4M 0.02% 693
2025
Q3
$69M Buy
700,471
+51,025
+8% +$5.06M 0.02% 631
2025
Q2
$59.2M Buy
649,446
+55,349
+9% +$5.35M 0.02% 668
2025
Q1
$67.2M Buy
594,097
+393,077
+196% +$42.1M 0.03% 580
2024
Q4
$21.2M Buy
+201,020
New +$21.6M 0.01% 1265

Other funds holding ZBH

Raymond James Financial's ZBH Position: Q2 2026 in Review

Raymond James Financial increased its Zimmer Biomet (ZBH) stake by 13% in Q2 2026, buying an estimated $9.03M and bringing the position to 866,170 shares worth $74.6M. The position accounts for 0.02% of the portfolio, ranked #709.

Raymond James Financial first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Raymond James Financial held 866,170 shares of Zimmer Biomet worth $74.6M as of Q2 2026.
  • Raymond James Financial bought 102,969 Zimmer Biomet shares in Q2 2026, an estimated $9.03M.
  • Zimmer Biomet made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #709 holding.
  • Raymond James Financial first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.